Molecular and Cellular Mechanisms of Lysosomal Storage Diseases
for
Lysosomal Storage Disorders
Location: Fairfax VA
Sponsor: O & O Alpan LLC
Sex: All
Age: 0 - 70+
Code: NCT02000310
Recruiting
Pilocarpine and Brimonidine in Patients With Monofocal Lenses
for
Presbyopia, Pseudophakia
Location: Boston MA
Sponsor: Massachusetts Eye and Ear Infirmary
Sex: All
Age: 60+
Code: NCT03825081
Early Phase 1, Recruiting
Treatment of Orthostatic Intolerance in Patients With Parkinson's Disease Using Midodrine
for
Orthostatic Intolerance, Parkinson's Disease
Location: Philadelphia PA
Sponsor: Corporal Michael J. Crescenz VA Medical Center
Sex: All
Age: 22 - 70+
Code: NCT02365012
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Genetic and Epigenetic Signatures of Translational Aging Laboratory Testing (GESTALT)
for
Healthy Volunteers, Non-Healthy/Non-Frail, Frail
Location: Baltimore MD
Sponsor: National Institute on Aging (NIA)
Sex: All
Age: 20 - 70+
Code: NCT02339012
Recruiting
Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes
for
Gestational Diabetes
Location: Iowa City IA
Sponsor: Anna Stanhewicz, PhD
Sex: Female
Age: 18 - 45
Code: NCT05917587
Early Phase 1, Recruiting
Effect of a Synbiotic Supplement on a High-protein Diet
for
Obesity
Location: Brookings SD
Sponsor: South Dakota State University
Sex: All
Age: 18 - 70+
Code: NCT03123510
Recruiting
A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia
for
Recurrent Severe Aplastic Anemia,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 0 - 70+
Code: NCT05757310
Phase 1, Recruiting
Neuroplasticity After Spinal Cord Injury
for
Spinal Cord Injury
Location: Chicago IL
Sponsor: Shirley Ryan AbilityLab
Sex: All
Age: 18 - 70+
Code: NCT02446210
Recruiting
Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy